Aesthetic device company Lynton Lasers has launched its distribution of the RedTouch PRO, following its initial unveiling at the Clinical Cosmetic Regenerative Congress (CCR) 2025.
Developed by manufacturing company DEKA, the new device is designed for the treatment of ageing, skin laxity, uneven tone and photodamage. Lynton Lasers explains that the new laser operates at a 675 nm wavelength which stimulates collagen types I, III and IV.
The company also shares that RedTouch PRO has a photobiomodulation effect with the aim to enhance fibroblast activity, extracellular matrix (ECM) regeneration and dermal thickness through selective thermal stimulation of collagen.
Dr Jon Exley, managing director of Lynton Lasers, commented, “RedTouch PRO is a genuine category innovation, it opens up a whole new treatment modality based on exclusive collagen targeting at a wavelength that no other laser system can match. We’re excited to partner with DEKA on this UK-first launch and look forward to supporting our partners with training, education and clinical success.”